Share Share on Facebook Share on Twitter Pinterest Email Cleo Diagnostics (COV:AU) has announced CLEO Further Expands Ovarian Cancer Trial with Siles Health Download the PDF here. This post appeared first on investingnews.com 0 Related Posts FPX Nickel Provides Update on 2025 Community Initiatives April 23, 2025 Lahontan Announces Upsize to Private Placement of Units April 23, 2025 Radisson Announces Fully Subscribed C$7 Million Private Placement April 23, 2025